PSG1
protein-codingpregnancy specific beta-1-glycoprotein 1, the group of V-set domain containing|CD molecules|Pregnancy specific glycoproteins
Gene summary
The human placenta is a multihormonal endocrine organ that produces hormones, enzymes, and other molecules that support fetal survival and development. Pregnancy-specific beta-1-glycoprotein (PSBG, PSG) is a major product of the syncytiotrophoblast, reaching concentrations of 100 to 290 mg/l at term in the serum of pregnant women (Horne et al., 1976 [PubMed 971765]). PSG is a member of the immunoglobulin (Ig) superfamily (Watanabe and Chou, 1988 [PubMed 3257488]; Streydio et al., 1988 [PubMed 3260773]).[supplied by OMIM, Oct 2009]
- PSBG1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~13.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PSG1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001184825.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 142 | 9 | 151 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 145 | 9 | 0 | 154 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001171754.1 | 6 | MANE Select | |
| Ensembl | ENSP00000413041.2 | 6 | MANE Select | |
| RefSeq | NP_001171755.1 | 6 | Standard | |
| RefSeq | NP_001284702.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Cell surface interactions at the vascular wall
- Hemostasis
Biological Process
- female pregnancy
- leukocyte migration
Molecular Function
- protein binding
Cellular Component
- extracellular region
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000244296
- Coding exons
- 5
- Length
- 13359
- Individuals with no LoFs
- 124057
- Homozygous LoFs
- 98
- Heterozygous LoFs
- 1505
- Defined
- 125660
- p
- 0.00640
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -6.11 | 495 | 233 | 2.13 | 0.0000135 | 2716 |
| Missense (PolyPhen) | 101 | 49.353 | 2.0465 | 673 | ||
| Synonymous | -5.73 | 158 | 89.2 | 1.77 | 0.00000497 | 854 |
| Loss of Function | -4.46 | 33 | 14.6 | 2.26 | 8.29e-7 | 172 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00050 | 0.00049 | rare |
| Latino/Admixed American | 0.0014 | 0.0014 | notable |
| Ashkenazi Jewish | 0.0011 | 0.0011 | notable |
| East Asian | 0.076 | 0.074 | notable |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0010 | 0.00096 | notable |
| South Asian | 0.0030 | 0.0027 | notable |
| Other | 0.0047 | 0.0046 | notable |
dbNSFP Gene Annotations
Source:
Intolerance Scores
- LoFtool
- 0.951
- RVIS EVS
- 1.85
- RVIS percentile EVS
- 97.15
Essentials
- Essential (CRISPR)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.449
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |